Credit: Coyne Scientific
Clinical Trials in a Dish (CTiD): The emergence of various hiPSC-derived cell types (cardiac, neuronal, hepatic) allows, for the first time, to combine the strengths of human diversity with the in vitro assessment of susceptibility to drug-induced toxicity.